Economics evaluation of alendronate versus ibandronate for postmenopausal osteoporosis in local community hospitals.
- In: Poster presentation
- At: Seoul (South Korea) (2017)
- Type: Poster
- Poster code: POS-PPR-005
- By: HUANG, Hsiao-Feng (Chi Mei Hospital, Chiali, Tainan, China Taiwan)
- Co-author(s): Hsiao-Feng Huang
BackgroundIn Taiwan, the medical costs in osteoporosis of postmenopausal women has a high socioeconomic impact on the individual and national health insurance. Bisphosphonates remain the mainstay for the treatment of osteoporosis in postmenopausal women and their effectiveness and costs vary considerably.
PurposeThe aims of the study were to.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019